CN104918621A - 包含含尼古丁材料和抗癌剂的产品 - Google Patents

包含含尼古丁材料和抗癌剂的产品 Download PDF

Info

Publication number
CN104918621A
CN104918621A CN201380060815.2A CN201380060815A CN104918621A CN 104918621 A CN104918621 A CN 104918621A CN 201380060815 A CN201380060815 A CN 201380060815A CN 104918621 A CN104918621 A CN 104918621A
Authority
CN
China
Prior art keywords
cancer
agent
nicotine
tobacco
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380060815.2A
Other languages
English (en)
Chinese (zh)
Inventor
巴兹尔·里格斯
杰森·里格斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN104918621A publication Critical patent/CN104918621A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/008—Electronic counters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/0083—Timers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F13/00—Appliances for smoking cigars or cigarettes
    • A24F13/02—Cigar or cigarette holders
    • A24F13/12—Cigar or cigarette holders combined with other objects, e.g. writing utensils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
CN201380060815.2A 2012-09-21 2013-09-23 包含含尼古丁材料和抗癌剂的产品 Pending CN104918621A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261703999P 2012-09-21 2012-09-21
US14/013,019 US20140088045A1 (en) 2012-09-21 2013-08-28 Product comprising a nicotine-containing material and an anti-cancer agent
US14/013019 2013-08-28
PCT/US2013/061206 WO2014047569A2 (en) 2012-09-21 2013-09-23 Product comprising a nicotine-containing material and an anti-cancer agent

Publications (1)

Publication Number Publication Date
CN104918621A true CN104918621A (zh) 2015-09-16

Family

ID=50339457

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380060815.2A Pending CN104918621A (zh) 2012-09-21 2013-09-23 包含含尼古丁材料和抗癌剂的产品

Country Status (9)

Country Link
US (2) US20140088044A1 (https=)
EP (1) EP2916847A4 (https=)
JP (1) JP2015531793A (https=)
KR (1) KR20150084794A (https=)
CN (1) CN104918621A (https=)
CA (1) CA2885739A1 (https=)
EA (1) EA201590585A1 (https=)
IN (1) IN2015DN02782A (https=)
WO (1) WO2014047569A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106455675A (zh) * 2014-03-11 2017-02-22 塞雷斯医疗用品公司 含有1,3‑丙二醇的组合物作为电子烟液的用途
CN108495563A (zh) * 2015-11-25 2018-09-04 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895321B2 (en) * 2010-04-23 2018-02-20 Aktiv-Dry Llc Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
EP3834869B1 (en) 2010-12-22 2024-06-05 Syqe Medical Ltd. System for drug delivery
WO2015148649A2 (en) * 2014-03-26 2015-10-01 Basil Rigas Systems and methods for ameliorating the effects of tobacco products
CA2944471C (en) * 2014-04-08 2020-03-31 Philip Morris Products S.A. Nicotine formulations and methods of making the same
CA2943746C (en) 2014-04-28 2023-08-15 Philip Morris Products S.A. Flavoured nicotine powder inhaler
RU2696570C2 (ru) 2014-04-28 2019-08-06 Филип Моррис Продактс С.А. Ингалятор никотинового порошка
UA122894C2 (uk) 2014-04-28 2021-01-20 Філіп Морріс Продактс С.А. Інгалятор нікотинового порошку
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
EP3871515B1 (en) * 2014-05-27 2025-04-16 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
GB2527597B (en) * 2014-06-27 2016-11-23 Relco Induction Dev Ltd Electronic Vapour Inhalers
RU2721064C2 (ru) 2014-06-30 2020-05-15 Сике Медикал Лтд. Ингалятор с регулированием потока
US11298477B2 (en) 2014-06-30 2022-04-12 Syqe Medical Ltd. Methods, devices and systems for pulmonary delivery of active agents
CN113616883B (zh) 2014-06-30 2023-06-06 Syqe医药有限公司 向受试者肺部递送植物材料中的至少一药理活性剂的系统
IL273507B2 (en) 2014-06-30 2024-06-01 Syqe Medical Ltd Methods, devices and systems for administering active substances through the lungs
RU2723335C2 (ru) 2014-06-30 2020-06-09 Сике Медикал Лтд. Дозовый картридж для ингалятора
AU2015283589B2 (en) 2014-06-30 2019-09-12 Syqe Medical Ltd. Method and device for vaporization and inhalation of isolated substances
EP4437859A3 (en) 2014-10-29 2024-11-27 Altria Client Services LLC Ethanol-free gel formulation cartridge for e-vaping device
EA201790930A1 (ru) 2014-10-29 2017-08-31 Олтриа Клайент Сервисиз Ллк Картридж электронного вейпингового устройства
CN104544542B (zh) * 2014-12-24 2017-04-26 广西中烟工业有限责任公司 一种真空冷冻干燥薄荷粒电子烟油的制备方法
GB2534210B (en) * 2015-01-19 2017-07-19 Ngip Res Ltd Aerosol-generating article
RU2716195C2 (ru) * 2015-04-15 2020-03-06 Филип Моррис Продактс С.А. Устройство для введения в ингалятор вкусового ароматизирующего вещества
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US9585835B1 (en) * 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
CN117695207A (zh) 2015-12-24 2024-03-15 菲利普莫里斯生产公司 带香味尼古丁粉末
EP3393560B1 (en) * 2015-12-24 2020-03-25 Philip Morris Products S.a.s. Nicotine powder delivery system
CA3008996A1 (en) 2015-12-24 2017-06-29 Philip Morris Products S.A. Nicotine particle capsule
CA3009599A1 (en) 2016-01-06 2017-07-13 Syqe Medical Ltd. Low dose therapeutic treatment
US9867397B2 (en) 2016-01-11 2018-01-16 Patrick Beymer Nicotine delivery system
GB201602831D0 (en) * 2016-02-18 2016-04-06 British American Tobacco Co Flavour delivery device
JP6976970B2 (ja) 2016-07-07 2021-12-08 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム ニコチン吸入器システム
US20180036496A1 (en) * 2016-08-02 2018-02-08 James Riviello Medication Delivery System
KR102877959B1 (ko) * 2018-12-28 2025-10-30 필립모리스 프로덕츠 에스.에이. 고 점도 니코틴 제형
JP7528084B2 (ja) * 2018-12-28 2024-08-05 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 金属塩を含むニコチン製剤
BR112021010229A2 (pt) 2018-12-28 2021-08-24 Philip Morris Products S.A. Formulação de nicotina líquida compreendendo sal de metal de baixa massa molar
JP7171910B2 (ja) * 2019-05-21 2022-11-15 日本たばこ産業株式会社 加熱型香味吸引器用香料含有シートおよび加熱型香味吸引器
US20220248744A1 (en) * 2019-07-15 2022-08-11 The Research Foundation For The State University Of New York Nicotine materials, methods of making same, and uses thereof
LU101519B1 (en) * 2019-12-02 2021-06-07 Herrera Arturo Solis (S)-3-[1-MethyIpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a solid substance and a tablet
WO2022102543A1 (ja) * 2020-11-13 2022-05-19 日本たばこ産業株式会社 センブラトリエンジオールを含むたばこ抽出物およびその製造方法
BR112023018676A2 (pt) 2021-03-18 2023-10-10 Seagen Inc Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco
WO2024090890A1 (ko) * 2022-10-27 2024-05-02 주식회사 케이티앤지 흡입용 저용량 니코틴 건조 분말 조성물
WO2024194922A1 (ja) * 2023-03-17 2024-09-26 日本たばこ産業株式会社 香味組成物及び香味吸引器

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050236006A1 (en) * 2004-04-24 2005-10-27 Anderson Cowan Smoking cessation devices, methods of use and methods of conducting business therewith

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2180788B1 (en) * 2007-08-10 2016-12-21 Basil Rigas Anti-inflammatory compounds and uses thereof
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
JP5469779B2 (ja) * 2010-04-19 2014-04-16 エスアールアイ インターナショナル 多発性骨髄腫の治療のための組成物および方法
WO2011133215A1 (en) * 2010-04-19 2011-10-27 Health Research Inc. Method of identifying and treating a person having a predisposition to or afflicted with parkinson disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050236006A1 (en) * 2004-04-24 2005-10-27 Anderson Cowan Smoking cessation devices, methods of use and methods of conducting business therewith

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KA WING CHENG, ET AL.: "Aerosol Administration of Phospho-sulindac Inhibits Lung Tumorigenesis", 《MOL CANCER THER.》 *
KA WING CHENG, ET AL.: "Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics", 《INTERNATIONAL JOURNAL OF ONCOLOGY》 *
T NIE, ET AL.: "Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo", 《BRITISH JOURNAL OF PHARMACOLOGY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106455675A (zh) * 2014-03-11 2017-02-22 塞雷斯医疗用品公司 含有1,3‑丙二醇的组合物作为电子烟液的用途
CN108495563A (zh) * 2015-11-25 2018-09-04 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物

Also Published As

Publication number Publication date
EA201590585A1 (ru) 2016-04-29
JP2015531793A (ja) 2015-11-05
WO2014047569A9 (en) 2014-05-30
CA2885739A1 (en) 2014-03-27
WO2014047569A2 (en) 2014-03-27
EP2916847A4 (en) 2016-06-08
IN2015DN02782A (https=) 2015-09-04
US20140088045A1 (en) 2014-03-27
KR20150084794A (ko) 2015-07-22
WO2014047569A3 (en) 2014-07-17
EP2916847A2 (en) 2015-09-16
US20140088044A1 (en) 2014-03-27

Similar Documents

Publication Publication Date Title
CN104918621A (zh) 包含含尼古丁材料和抗癌剂的产品
WO2015148649A2 (en) Systems and methods for ameliorating the effects of tobacco products
EP2711006A1 (en) Product Comprising a Nicotine-Containing Material and an Anti-Cancer Agent
US20140178461A1 (en) Compounds and compositions for use in the treatment and prevention of lung and brain cancer and precancerous conditions thereof
CN101371843B (zh) 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
US20130225529A1 (en) Phospho-ester derivatives and uses thereof
ES2821907T3 (es) Sal de nicotina con ácido metasalicílico
ES2733998T3 (es) Agente terapéutico específico de enfermedad pulmonar
RU2536115C2 (ru) Система генерирования никотинового аэрозоля на основе табака
EP2477607B1 (en) Improved device and method for delivery of a medicament
US8476314B2 (en) Substance with sedative effect
MXPA01004188A (es) Inhaladores de dosis medida de solucion de 9 tetrahidrocanabinol ( 9 thc) y metodo de uso.
JP2021185170A (ja) 経口吸入及び経鼻用ベンゾジアゼピン
EP1439827A2 (en) Inhalation of vapour of therapeutical substances
US20140315834A1 (en) Compounds and compositions for use in the prevention and treatment of inflammation-related disorders, pain and fever, skin disorders, cancer and precancerous conditions thereof
ES2207867T3 (es) Preparacion farmaceutica para inhalacion de un opioide.
BR102012026195B1 (pt) método de preparação de uma formulação de nicotina adequada para inalação e método para a realização de uma terapia de substituição ou retirada de tabaco
Islam et al. Improved treatment of nicotine addiction and emerging pulmonary drug delivery
CN104470510A (zh) 一种基于前列腺素的支气管松解药
US20230117531A1 (en) Dried particle inhalation for delivery of cannabis
CN117417281A (zh) 抗炎、抗癌和抗血管生成化合物，药物组合物及其制备和使用方法
HK1249400A1 (en) Nicotine salt with meta-salicylic acid
Feldman et al. Nicotine Delivery to Rats via Lung Alveolar Region-Targeted Aerosol Technology Produces Blood Pharmacokinetics Resembling Human Smoking
JP2010507628A (ja) 骨ガンの処置又は予防のためのｍｔｋｉ１の使用
WO2008038160A2 (en) A substance with sedative effect for use in the treatment of neurotic disorders

Legal Events

Date Code Title Description
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150916